Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REGYNERA(Dia)TION: An Ambispective International Multicenter Patient Registry of Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Malignancies

NCT07667192 is registered in ClinicalTrials.gov with Affidea Nu-med Center of Oncological DIagnostics and Therapy as lead sponsor.

NCT NCT07667192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07667192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REGYNERA(Dia)TION: An Ambispective International Multicenter Patient Registry of Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Malignancies
Lead sponsor
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase
Observational
Overall status
Recruiting
Start date
June 11, 2026
Completion date
December 31, 2036
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary peritoneal cancer, recurrent cervical cancer, recurrent fallopian tube cancer, recurrent gynecologic cancer, recurrent ovarian cancer, recurrent uterine cancer, recurrent vaginal cancer, recurrent vulvar cancer